The FAIS Council comprises of the president, vice-president, treasurer, secretary general and past president of FAIS. The council members are elected at the meeting of the Federation held every 3 years. The council is supported by councillors and advisors.
Henry Mwandumba (President)
Henry Mwandumba is a Clinician Scientist and Deputy Director of the Malawi-Liverpool-Wellcome Trust Clinical Research Programme (MLW), University of Malawi College of Medicine and Consultant Physician at Queen Elizabeth Central Hospital in Blantyre, Malawi. He is Head of the Immunology Research Group at MLW.
Henry studied medicine at the University of Zimbabwe School of Medicine and specialised in General (Internal) Medicine and Infectious Diseases in Liverpool, UK. His research focuses on understanding the effects of HIV on pulmonary immunity and predisposition to respiratory infections, especially tuberculosis. He is President of the Immunology Society of Malawi (ISM) and Treasurer of the East, Central and Southern Africa College of Physicians (ECSACoP).
Henry’s research is supported by funding from the Wellcome Trust, Bill & Melinda Gates Foundation , National Institutes of Health and the Medical Research Council (UK) through the MRC/DfID African Research Leader Award.
Pa Tamba Ngom (Vice President)
Dr. Pa Tamba Ngom is the current Vice President and held the positions of Secretary General and Treasurer of FAIS from 2009 to 2017. He is the Founder Secretary General of The Gambia Immunological Society (GAMIS).
He studied Biochemistry at Exeter, UK, and is a Fellow of the Institute of Biomedical Sciences, UK. He has an MSc in Molecular Medicine and a PhD in Immunology from Imperial College London. He is a Consultant for Clinical and Research Laboratory Quality Management Systems Strengthening, with over 25 years of hands-on experience.
Clive Gray (Secretary General)
Clive Gray is full Professor and Chair of the Division of Immunology at the University of Cape Town, Institute of Infectious Diseases and Molecular Medicine and Department of Pathology, with a joint appointment to the National Health Laboratory Service. He is the Director of the Tissue Immunology diagnostics lab within the NHLS at Groote Schuur Hospital, Cape Town.
He holds a Faculty position as Adjunct Professor in the Department of Immunology, Duke University, North Carolina, USA. He graduated with an MSc and PhD from the University of the Witwatersrand and undertook a post-doc at Stanford University from 1996-98. On returning to South Africa, he became head of HIV Immunology at the National Institute for Communicable Diseases until 2010.
From 2011, he has been at UCT in his present position. His focus has shifted from measuring T cell epitope recognition and the dynamics of T cells during acute HIV infection to understanding immune regulation and T cell activation within mucosal and epithelial surfaces and the risk of HIV infection. He is also investigating immune ontogeny in HIV exposed uninfected newborn infants and how HIV infection on mothers on ARV treatment impacts on fetal-maternal tolerance.
He is the founder of Immunopaedia in 2005, now the official IUIS education on-line learning site, which was the outcome of the International Leadership Award from the Elizabeth Glaser Pediatric AIDS Foundation. He is the Vice-Chair of the Education Committee of the IUIS and he will be the co-Chair of the IUIS International Conference on Immunology in 2022, to be held in Cape Town.
Abdallah Badou (Treasurer)
Dr. Abdallah Badou is a Professor of Immunology at the Faculty of Medicine and Pharmacy at Casablanca Hassan II University, Morocco. Dr. Badou has completed his PhD in Immunology in 1998 at Paul Sabatier University (Toulouse, France). Afterwards, He joined the Immunobiology department at Yale University School of Medicine (Connecticut, USA) from 1999 to 2007. In 2007, He joined Cadi Ayyad University in Morocco as assistant then qualified professor (2007 to 2014). Since 2014, Dr. Badou was affiliated to the Faculty of Medicine and Pharmacy of Casablanca.
His current research topics are related to the study of the immune response in inflammation and cancer. He is currently the secretary general of the Moroccan Society of Immunology (SMI). Dr. Badou is an Associate Editor for several journals including BMC Immunology.
Hatem Masmoudi (past-President)
Immunology Department, Habib Bourguiba Hospital, 3029-Sfax, TUNISIA
Tel: +216 74 451 660
Mobile: +216 98 413 954
Hatem Masmoudi (MD/PHD) studied at the Faculty of Medicine of Sfax and the Faculties of Science of Sfax and Tunis. He continued his training in immunology at the Necker Hospital (Pr Jean François Bach) and the Pasteur Institute (Pr Pierre André Cazenave) in Paris.
Currently he is a Professor in Medicine and Head of Immunology Department of the Medical School and Habib Bourguiba Hospital of Sfax, where he heads the Research Unit UR12/SP46 "Autoimmunity and Immunogenetics".
After immunoglobulins allotypy and idiotypy and CD5+ B cell repertoires, his research conducted these last twenty years focuses on the immunogenetic and environmental factors of susceptibility to autoimmune diseases, mainly pemphigus, type 1 diabetes, lupus and inflammatory bowel diseases.
Hatem Masmoudi was Vice President of the Tunisian Society of Clinical Biology (www.stbc.org.tn) and Chairman of its scientific committee (1999-2005). After being its treasurer, Secretary General and President (2004-2014), he is now the Past-President of theTunisian Society of Immunology (www.immunology.org.tn)
Committee Member :
Dr. Uzonna is a Professor Associate Head of the Department of Immunology at the University of Manitoba, Senior Scientist at the Children’s Research Institute of Manitoba and Leader of the Parasite Vaccines Development Laboratory at the College of Medicine, University of Manitoba.
He obtained a Doctor of Veterinary Medicine (DVM) degree with distinctions from the University of Nigeria, a Ph.D. (Immunology) from the University of Saskatchewan and did his postdoctoral fellowship training at the University of Pennsylvania, Philadelphia. His research focuses on understanding cellular and molecular mechanisms that regulate induction, maintenance and loss of protective immunity against parasitic infections with a goal to develop effective vaccines and/or vaccination strategies against these infections.
Dr. Uzonna has received numerous professional, community, teaching, academic and research awards, the most recent includes Canadian Society for Immunology (CSI) Investigator Award, Ken Hughes Award for Outstanding Achievement in Biomedical Research, Research Manitoba Chair Professor in Immunology and Manitoba Black Community Award for Outstanding Achievement in Mentoring and Education.
He is (or has served as) a member of editorial board of many international and high impact journals and has extensive grant review experience including reviewing for NIH, CIHR, NSERC, Genome Canada, Heart and Stroke Foundation, Medical Research Council (Britain), European Union, etc.
Email : email@example.com / firstname.lastname@example.org
Tel: + 221 77 737 53 91 / + 221 77 649 42 07
PharmD, MSc, PhD
Member of Executive Committee of FAIS
Treasurer of Senegalese Society of Immunology
Dr. B. Mbengue is Professor of immunology in University Cheikh Anta Diop (Dakar/Senegal) and Associate researcher in the Immunogenetic Unit of Institut Pasteur de Dakar. He is involved in immunological and genetics studies on malaria infection, breast and cervical cancers.
His principal research activity interests are focused one immunology of P falciparum infection with different parts such as research of immunogenetic biomarkers for disease’s severity or prognostic value, and vaccinology research with potential vaccines candidates against malaria.
Professor Dorothy Yeboah-Manu is the Head of Bacteriology Department, Noguchi Memorial Institute for Medical Research. She holds a PhD in Microbiology from the University of Basel, masters in Applied Molecular Biology of Infectious Diseases.
London School of Hygiene and Tropical Medicine. She is the vice president of the Immunological Society of Ghana, a member of the Graduate School Board, University of Ghana, American Society for Microbiology, International Union against Tuberculosis and Lung Disease and the WHO Global Network of Laboratories Confirming Mycobacterium ulcerans Infection (Buruli ulcer).
She is the chairperson of the Advisory Board of the National Tuberculosis Control Program and a member of the Steering Committee of the National Buruli ulcer Control Program. Her research activities focus on host and pathogen interactions, diagnosis and molecular epidemiology of tuberculosis and Mycobacterium ulcerans disease. Her main funding has come from the UBS/Optimus Foundation, Royal Society/Leverhulme African awards scheme, VolksWagen Foundation and the Wellcome Trust.
Nana Al Sheikh